Welcome to our dedicated page for Kenvue SEC filings (Ticker: KVUE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Kenvue Inc. filings document the public-company disclosures of a pure-play consumer health issuer with brands including Tylenol, Listerine, Johnson’s, Aveeno, Neutrogena and BAND-AID Brand. Its SEC record includes material-event reports, proxy and governance disclosures, shareholder voting matters, capital-structure information, operating and financial results, and consumer-health regulatory topics.
The company’s filings also cover executive officer appointments and compensatory arrangements, material definitive agreements, risk-factor disclosures and common-stock matters. Proxy materials and Form 8-K reports provide formal records of board governance, security-holder votes and other events affecting Kenvue’s corporate structure and reporting obligations.
Kenvue outlines how its proposed acquisition by Kimberly-Clark would affect employees and shareholders. For shareholders, each Kenvue share is expected to convert at closing into $3.50 in cash plus 0.14625 shares of Kimberly-Clark, with cash paid instead of fractional Kimberly-Clark shares. Unvested Kenvue RSUs and PSUs would convert into unvested Kimberly-Clark RSUs, with value preserved and vesting generally continuing, and full vesting if employment is terminated without cause or for good reason within two years after closing.
Kimberly-Clark has agreed to maintain current salary and target bonus levels for at least one year after closing, including normal pay review increases, and to provide target long-term incentives consistent with similarly situated Kimberly-Clark employees. Kenvue expects no changes to major medical, leave, or well-being benefits in 2026 if closing occurs in the second half of the year, although future integration decisions will be made by Kimberly-Clark. The communication also highlights ongoing recognition and well-being programs and reminds investors that detailed terms are described in an effective Form S-4 and joint proxy statement/prospectus on file with the SEC.
Kimberly-Clark Corporation has filed a shareholder engagement presentation related to its proposed transaction with Kenvue Inc.. The communication explains that the deal will be submitted to both companies’ stockholders using a joint proxy statement and prospectus included in a Kimberly-Clark registration statement on Form S-4, which has been declared effective by the SEC and mailed to stockholders.
The material stresses that this document is not an offer to sell or buy securities and directs investors to the effective registration statement and definitive joint proxy statement/prospectus for full details of the proposed transaction, including participant information and potential interests of directors and officers. It also includes extensive forward-looking statement and risk disclosures, outlining that expected benefits, synergies, financing plans and combined financial projections are uncertain and subject to numerous business, regulatory, market, and integration risks.
Kimberly-Clark Corporation filed this communication under securities solicitation rules in connection with its proposed transaction with Kenvue Inc.. It highlights that a Form S-4 registration statement, including a joint proxy statement/prospectus covering the proposed issuance of Kimberly-Clark common stock, has been declared effective and mailed to both companies’ stockholders to seek approval of transaction-related proposals.
The text urges investors and stockholders of both companies to carefully read the registration statement and definitive joint proxy statement/prospectus, which are available for free on the SEC’s and each company’s websites. It also explains that statements about expected benefits, synergies, cash flow, capital structure and growth from combining the businesses are forward-looking and subject to many risks, including deal completion, integration challenges, regulatory approvals, litigation, market conditions and changing consumer behavior.
The communication further notes that projected combined financial information is based on management estimates, is illustrative only, does not follow Regulation S-X pro forma requirements and should not be viewed as a substitute for each company’s historical financial statements.
Kenvue Inc. reported an equity award to its Chief Financial Officer in an insider transaction filing. On 01/02/2026, the officer received 144,341 restricted stock units, each corresponding on a 1-for-1 basis to Kenvue common stock. The award was acquired at a price of $0 as a grant rather than a market purchase.
The 144,341 units vest in three equal installments on 01/02/2027, 01/02/2028, and 01/02/2029, conditioned on the officer’s continued service through each vesting date. Following this grant, the officer directly holds 144,341 derivative securities tied to Kenvue common shares.
Kenvue Inc. reported an equity award to its Chief Digital & Marketing Officer on a Form 4. On 01/02/2026, the officer received 34,642 restricted stock units, each corresponding on a 1-for-1 basis with Kenvue common stock. These units are scheduled to vest in three equal installments on 01/02/2027, 01/02/2028, and 01/02/2029, contingent on the officer’s continued service with the company through each vesting date. After this grant, the officer directly holds 34,642 derivative securities linked to Kenvue common shares at no exercise price, reflecting a standard form of stock-based compensation.
Kenvue Inc. reported an amended insider transaction for its Chief Executive Officer on a Form 4/A. On 12/15/2025, 56,007 shares of Kenvue common stock were withheld to cover taxes due when Restricted Stock Units vested. The filing explains that this amendment is being made because the number of shares previously reported as withheld for taxes was over-withheld due to an administrative error, and the share amount has now been adjusted.
Kenvue Inc. reported an insider equity award for its Group President North America dated 12/15/2025. The executive acquired 50,842 restricted stock units and 483,870 stock options linked to Kenvue common stock.
The restricted stock units correspond 1-for-1 with the company’s common shares. The filing notes that the award vests in three equal installments on 12/01/2026, 12/01/2027, and 12/01/2028, subject to the executive’s continued service. Following these grants, the reporting person beneficially owns 50,842 restricted stock units and 483,870 stock options, all held directly.
Kenvue Inc. reported equity award activity for its Chief Corporate Affairs Officer on 12/15/2025. The officer converted restricted stock units into 2,752.06 and 2,155.93 shares of common stock at an exercise price of $0, then had 1,408 and 1,103 shares withheld at $17.21 per share to cover taxes, resulting in 4,101.14 shares of common stock held directly.
The RSU awards each correspond 1-for-1 with Kenvue common stock and include shares from dividend reinvestment. One award was scheduled to vest in three equal installments on 06/03/2025, 06/03/2026, and 06/03/2027, and another on 03/10/2026, 03/10/2027, and 03/10/2028. Portions scheduled for 06/03/2026 and 03/10/2026 vested early as part of “Section 280G Mitigation” related to a pending transaction between Kenvue and Kimberly-Clark, and the accelerated awards are subject to clawback if it is later determined the officer would not have ultimately vested in them.
Kenvue Inc.'s chief executive officer reported an equity award transaction dated December 15, 2025. On that date, 118,561.65 restricted stock units converted on a one-for-one basis into the same number of Kenvue common shares at an exercise price of $0.
Of the shares received, 66,614 were withheld at a price of $17.21 per share to cover taxes, leaving 51,947.65 common shares directly owned after the transaction. The vesting was accelerated from an original schedule of July 14, 2026 to mitigate the adverse impact of Section 280G of the Internal Revenue Code in connection with a pending transaction between Kenvue and Kimberly-Clark Corporation, and the award is subject to clawback if it is later determined the executive would not have ultimately vested absent this acceleration.
Kenvue Inc. reported an amended insider ownership report for its Group President APAC, reflecting a grant of 32,649 restricted stock units (RSUs) awarded on 07/31/2025. These units correspond 1-for-1 with Kenvue common stock and were granted at a price of $0, so the executive did not pay cash for the award.
The RSU grant vests in three equal installments on 07/31/2026, 07/31/2027, and 07/31/2028, subject to the executive’s continued service through each vesting date. After this grant, the reporting person beneficially owns 48,147.25 RSUs, which includes units credited as dividend equivalents. The amendment states that a prior ownership report inadvertently omitted this 32,649-unit RSU grant and is being corrected here.